Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/215708
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Lipid Vesicles Loaded with an HIV-1 Fusion Inhibitor Peptide as a Potential Microbicide |
Autor: | Sánchez-López, Elena; Paús, Anna CSIC; Pérez-Pomeda, Ignacio CSIC ORCID ; Calpena, A.; Haro Villar, Isabel CSIC ORCID ; Gómara Elena, María José CSIC ORCID | Palabras clave: | Microbicides Drug delivery system Nanoparticles Fusion inhibitor peptide Vaginal mucosa |
Fecha de publicación: | 31-may-2020 | Editor: | Multidisciplinary Digital Publishing Institute | Citación: | Pharmaceutics 12(6): 502 (2020) | Resumen: | The effective use of fusion inhibitor peptides against cervical and colorectal infections requires the development of sustained release formulations. In this work we comparatively study two different formulations based on polymeric nanoparticles and lipid vesicles to propose a suitable delivery nanosystem for releasing an HIV-1 fusion inhibitor peptide in vaginal mucosa. Polymeric nanoparticles of poly-d,l-lactic-co-glycolic acid (PLGA) and lipid large unilamellar vesicles loaded with the inhibitor peptide were prepared. Both formulations showed average sizes and polydispersity index values corresponding to monodisperse systems appropriate for vaginal permeation. High entrapment efficiency of the inhibitor peptide was achieved in lipid vesicles, which was probably due to the peptide’s hydrophobic nature. In addition, both nanocarriers remained stable after two weeks stored at 4 °C. While PLGA nanoparticles (NPs) did not show any delay in peptide release, lipid vesicles demonstrated favorably prolonged release of the peptide. Lipid vesicles were shown to improve the retention of the peptide on ex vivo vaginal tissue in a concentration sufficient to exert its pharmacological effect. Thus, the small size of lipid vesicles, their lipid-based composition as well as their ability to enhance peptide penetration on vaginal tissue led us to consider this formulation as a better nanosystem than polymeric nanoparticles for the sustained delivery of the HIV-1 fusion inhibitor peptide in vaginal tissues. | Descripción: | © 2020 by the authors. | Versión del editor: | https://doi.org/10.3390/pharmaceutics12060502 | URI: | http://hdl.handle.net/10261/215708 | DOI: | 10.3390/pharmaceutics12060502 | ISSN: | 1999-4923 | E-ISSN: | 1999-4923 |
Aparece en las colecciones: | (IQAC) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Lipid_Sanchez_Lopez_Art2020.pdf | 903,07 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
4
checked on 11-abr-2024
SCOPUSTM
Citations
9
checked on 16-abr-2024
WEB OF SCIENCETM
Citations
8
checked on 25-feb-2024
Page view(s)
104
checked on 18-abr-2024
Download(s)
122
checked on 18-abr-2024